Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Clinical trial NCT00025220 · COMPLETED

Trial details

NCT number: NCT00025220
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Uterine Corpus Sarcoma Uterine Corpus Leiomyosarcoma

Start date: 2001-09-01
Primary completion: 2003-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.